{"name":"Portage Biotech","slug":"portage-biotech","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFByUFVrVm9HS1M1VDlacGhYdDlzeC1BTV9zbDRwVkRpcHQ2eDV6d0RVQmREYlowdGJQYzc2SnlVU283cWx6OGJXNVc0WHEzYjd4aURSeklqVmhjaUFRX2ltb19MN3k3S190MWpfdw?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Novabay Pharma (NBY) - Stock Titan","headline":"If You Invested $1,000 in Novabay Pharma (NBY)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"bolsamania.com","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - bolsamania.com","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOQjc1aUxaRWNPcWtUaEVVNEN5c3FIN0xQVHg2M1V4WXI0Tmc2cWpzM2xadTNDeEJUZzFxSDRGOXZWWlFZM0Q4SFVkRTBRcmhmNXIzLUZXM2VfZkdkdVN1MFBENV9YaFFfVzRyMWFSNjNiY3I3alVmUTlfZDY1NWdIMFF5N2xrajVqTmx3MUFGcE0?oc=5","date":"2025-09-04","type":"pipeline","source":"IndexBox","summary":"Portage Biotech Rebrands to AlphaTON with $100M Crypto Strategy - News and Statistics - IndexBox","headline":"Portage Biotech Rebrands to AlphaTON with $100M Crypto Strategy - News and Statistics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9pMUNpWmcwMEZac0FEd0drUkZpcUhGUTd5aUV4WmkyX1VnX0FFWVlhOElqdG1qa3gycFh2S00wREhsWGtEWnVadURaQlY1NHI3VXhJ?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"PRTG Stock Price, News & Analysis | Portage Biotech - Stock Titan","headline":"PRTG Stock Price, News & Analysis | Portage Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNOGtNU2lodTQ0VTNwbTczbGphS3B4eEZqdjBxZVVOWFVGMmNGQzNuVEV1RWE3VnB0cGprZk5wd25HYzhGNnoxend6cVJ2NmU1VTdXQWhGcVRCalpKcXR0MEVGZjd1QVpjYlRCT3M5WEdzZVR4Y1NSdWRlSjhqcHlpYWZsNkEydHF5aEJSelgwTk5xdmptUDZQLVdsMGJDVlFwS0J0MXhBcVlLUQ?oc=5","date":"2024-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova - Fierce Biotech","headline":"Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZ285SmZING9xRS1jRU95YXNGUXNCV0x1MGZvdU5SNnVRdDh6ZHhXaWtrbTFxM1dNV19aWE0zSFdCMThpQTNIX1JqSG5SY2hoamtyN2ZEY3RscDlCYU9QYWZaYmRSQ0FqRnRIeDkzTHUzbUF2NjJsM2dHdHI0R210SmdIc0E3Q2VrcWZiSDVpVDktZ0pXU3d2cVZWWTQwMzloWUVQNC1mWDNOZw?oc=5","date":"2024-04-12","type":"pipeline","source":"Fierce Biotech","summary":"Portage Biotech hints at potential closure as it halts programs, hunts for strategic options - Fierce Biotech","headline":"Portage Biotech hints at potential closure as it halts programs, hunts for strategic options","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPQWUwZWRvTHFMRV93b0FZWjU5TGpTb2dSRTNabFpTQVN4d1RLejMxQ0duTEVuc1VFdXJtTGJwRjJiTDBuLTJxSVQ0QTVleU02V25hTTJhTnk0aTVRandtY29PcDBFUTZQUEl6QTN1aHlVQ3RTY1ZQd2pyeWVZTDRQaw?oc=5","date":"2023-09-01","type":"pipeline","source":"Life Science Leader","summary":"To America, A New Biopharma Model - Life Science Leader","headline":"To America, A New Biopharma Model","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxNQ1NscmRVbXVIeUNjcmNzb1k5cUoxLVRBSnVzMWZ1V1dVSmRfbXltVEdEWVZRRVFYdEE5dUpFdHA0eVFDNXYzNzhLQld2RjFKMXhUbzNWbUk5NGlJSFNxaTRRNkJYSmdISE5mUXRCMHVSN3ZuUU1TOGdzTHVLMHROSkU1V1ZmZTZPYXFZcG9MYUxnYTh0SjVzWmRnX0xyZDRaZkc1aHU2Y3hwd2lRSWxvSmhtbjBoYVo0Y3lGUk40Z2VPSTdYZnduY1Z1SU4zYTRmRjRrVTJGcE1vWUdWQ2c3UWd2dzNMQ1R3X3NqRUEweEpjNE1rMlRxckN4RkdiVHN1T2R2a0FUTEdlbkd2aVlTalBvcFJfM1lZb0ZDSlBTWXRMNE5sSHl0ZFZjSQ?oc=5","date":"2023-04-26","type":"pipeline","source":"GlobeNewswire","summary":"Portage Biotech Announces Upcoming PORT-2 Poster - GlobeNewswire","headline":"Portage Biotech Announces Upcoming PORT-2 Poster","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOYWNCa0tMbDBoTWhUUThTWXdlQUtaR2gyWTRFMmpubmJZdGgxaXUwbUUwNFJ1QXhLUHd3eTI3am1hdGFHSUM3ZUs3NUpmblI5Y2h0NUFJczJ2LTZ4S2ZQTjRpNUpYOEp5ajc4R3JyejkybEtvLUotV0xUOE5tTkxHQXIwWGVuV2NZMGpmZ3EzT2RqenVVN3RWVmtBRUc4cTk5T1E?oc=5","date":"2023-04-05","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Making the Transition from Academia to CEO - Genetic Engineering and Biotechnology News","headline":"Making the Transition from Academia to CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQQWE4ZHowQk9uVWFwWDV5Nm4ycWdycmxsOTRVcy1KZnI2ME1RZVp0WFNyeFlyM2pNbExqLUZvNHlyRE5qekxtSmNqYi1sbTdfeHUwUURjdEZZNlJLNFpid1VfUUNFR0pQY3lkZ3p5dFpJZEx3R2FmZXhpelZkX0RqQ2FpMGdqOHNmNm5VNUowa2ZDZHBVNTI0?oc=5","date":"2022-11-21","type":"pipeline","source":"clinicalleader.com","summary":"Portage Biotech Creates A New Drug Development Model - clinicalleader.com","headline":"Portage Biotech Creates A New Drug Development Model","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNUFpzSGpuNVJrel9iOGxyQWZlcTZBeVZTY3NxdXFvWTREMGRlUUNjbVZ2TmFURXR2Vy10aU1RMHMtNnpTd2ViajIzNW9hREVqQXR4bzlQOVp3TDFKQUlsak93SUlZZEJINTNFSmg1eUEwcC1fU0lvd1NzTUJEcWNDMmljZDluZw?oc=5","date":"2022-09-06","type":"pipeline","source":"Pharma Voice","summary":"The 2022 PharmaVoice 100 - Pharma Voice","headline":"The 2022 PharmaVoice 100","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOVDd0SkdXblh5M2NhSGN2alhFOThMRXI5QmlQbFRjV0hqZ1hBYnlCSnpYUVZEMURCWEN6MHRLcE9oSk90dEJ2RHBjbk5DUVRYQVhXNlNjNURiXzBVQ3c3TjFZNVR3MDFjTlFucTVuTWtBaUsxaEVWeFBVMGRpakx4MEE5UXBDaDNBa01ycHVYYnIxS21CWUpjTm9xOWlhdkY5?oc=5","date":"2022-07-08","type":"pipeline","source":"BioProcess International","summary":"Portage targets adenosine pathway with Tarus acquisition - BioProcess International","headline":"Portage targets adenosine pathway with Tarus acquisition","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}